Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Pediculicide Resistance Not Well Understood - Lancet Editorial

This article was originally published in The Tan Sheet

Executive Summary

The mechanism by which head lice become resistant to pediculicides needs further study, Howard Maibach, MD, University of California at San Francisco, et al., suggest in the Aug. 12 issue of The Lancet.

You may also be interested in...



Lindane Ban Request Presents Chance To Promote Natural Lice Solutions

The insecticide agent lindane used in lice treatments is hazardous, ineffective and bad for the environment, Rep. Markey says in a letter to FDA. Growing criticism of the use of harsh chemicals could create opportunities for natural solutions to grow sales.

Lindane Ban Request Presents Chance To Promote Natural Lice Solutions

The insecticide agent lindane used in lice treatments is hazardous, ineffective and bad for the environment, Rep. Markey says in a letter to FDA. Growing criticism of the use of harsh chemicals could create opportunities for natural solutions to grow sales.

Piedmont Hopes Pediculicide Will Produce Resultz In Phase III Trials

Piedmont Pharmaceuticals was granted approval to begin Phase III clinical trials on its insecticide-free Resultz pediculicide rinse, the Greensboro, N.C.-based firm announced March 17

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS091575

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel